A plus AVD for Treatment of Hodgkin Lymphoma Variant of Richter's Transformation

被引：0

作者：

Heyman, Benjamin ^{[1
]}

Choi, Michael ^{[2
]}

Kipps, Thomas J. ^{[3
]}

机构：

[1] UC San Diego Moores Canc Ctr, Dept Med, Div Regenerat Med, UC San Diego, La Jolla, CA 92093 USA

[2] Dept Med, Div Hematol Oncol, UC San Diego, La Jolla, CA 92093 USA

[3] Ctr Novel Therapeut, Dept Med, Div Hematol Oncol, UC San Diego, La Jolla, CA 92093 USA

来源：

CASE REPORTS IN HEMATOLOGY | 2024年 / 2024卷

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; BRENTUXIMAB VEDOTIN; PHASE-II; CHEMOTHERAPY; VENETOCLAX; OUTCOMES; THERAPY; DISEASE; ABVD; MOPP;

D O I：

10.1155/2024/7612622

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hodgkin lymphoma variant of Richter's transformation (HvRT) is a rare complication for patients with chronic lymphocytic leukemia (CLL), with an overall poor prognosis. We present the first known case series of patients with HvRT treated with the combination of brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A + AVD). In our series of 4 patients, two patients treated with A + AVD for HvRT had durable remissions of 40 and 42 months, while two patients had disease progression and ultimately died. Continued investigation into the optimal management for patients with HvRT is still needed.

引用

页数：8

共 50 条

[41] Concurrent Pembrolizumab With AVD for Untreated Classical Hodgkin Lymphoma
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 11 - 12
[42] Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
Lynch, Ryan C.
Ujjani, Chaitra S.
Poh, Christina
Warren, Edus H.
Smith, Stephen D.
Shadman, Mazyar
Shustov, Andrei R.
Till, Brian G.
Tseng, Yolanda D.
Coye, Hilary
Shelby, Megan
Ottemiller, Susan
Du, Hongyan
Vandermeer, Jacquelin
Rasmussen, Heather A.
Alig, Stefan
Alizadeh, Ash A.
Gulhane, Avanti
Chen, Delphine
Dean, Eric Wayne
Lukas, Jason
Martin, Paul S.
Marzbani, Edmond A.
Voutsinas, Jenna
Gopal, Ajay K.
BLOOD, 2021, 138
[43] Hodgkin's disease variant of Richter's syndrome: Experience at a single institution
Fayad, L
Robertson, LE
OBrien, S
Manning, JT
Wright, S
Hagemeister, F
Cabanillas, F
Keating, MJ
LEUKEMIA & LYMPHOMA, 1996, 23 (3-4) : 333 - 337
[44] Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine
Jamroziak, Krzysztof
Grzybowska-Izydorczyk, Olga
Jesionek-Kupnicka, Dorota
Gora-Tybor, Joanna
Robak, Tadeusz
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (02) : 286 - 288
[45] Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-Like lesion
Xiao, Wenbin
Chen, Wayne W.
Sorbara, Lynn
Davies-Hill, Theresa
Pittaluga, Stefania
Raffeld, Mark
Jaffe, Elaine S.
HUMAN PATHOLOGY, 2016, 55 : 108 - 116
[46] Hodgkin Variant of Richter's Transformation (HvRT) Among Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC), Canada
Zhu, Kai
Jamroz, Andrew
Huang, Steven J. T.
Villa, Diego
Freeman, Ciara L.
Scott, David W.
Slack, Graham W.
Sehn, Laurie H.
Connors, Joseph M.
Toze, Cynthia L.
Savage, Kerry J.
Gerrie, Alina S.
BLOOD, 2020, 136
[47] EVEROLIMUS PLUS SORAFINIB FOR THE TREATMENT OF HODGKIN LYMPHOMA
Johnston, P. B.
Kumar, S.
Porrata, L.
Micallef, I. N.
Habermann, T.
Colgan, J.
Laplant, B.
Witzig, T.
ANNALS OF ONCOLOGY, 2011, 22 : 181 - 181
[48] Prolonged persistence of SARS-CoV-2 infection during A plus AVD therapy for classical Hodgkin's lymphoma: A case report
Fujii, Hiroyuki
Tsuji, Taisuke
Sugitani, Mio
Matsumoto, Yosuke
Yuba, Tatsuya
Tanaka, Shunya
Suga, Yoshifumi
Matsuyama, Aosa
Goda, Shiho
Omura, Ayaka
Shiotsu, Shinsuke
Takumi, Chieko
Ono, Seiko
Hiraoka, Noriya
CURRENT PROBLEMS IN CANCER, 2021, 45 (06)
[49] Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature
Bockorny, Bruno
Codreanu, Ion
Dasanu, Constantin A.
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (01) : 50 - 66
[50] Hodgkin's Variant of Richter Transformation in Chronic Lymphocytic Leukemia; A Retrospective Study from the Israeli CLL Study Group
Tadmor, Tamar
Shvidel, Lev
Goldschmidt, Neta
Ruchlemer, Rosa
Fineman, Riva
Bairey, Osnat
Rahimi-Levene, Naomi
Herishanu, Yair
Yuklea, Mona
Arad, Ariela
Aviv, Ariel
Polliack, Aaron
ANTICANCER RESEARCH, 2014, 34 (02) : 785 - 790

← 1 2 3 4 5 →